Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2026-04-16 18:30:05 ET · period of report 2026-04-14 · accession 0001193125-26-159539 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-16 18:30 | 2026-04-14 | KYMR | Goodman Noah | Chief Business Off | S - Sale | $90.00 | -1,347 | 50.2K | -3% | -$121.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-14 | S | D | 1,347 | $90.00 | 50,195.44 | D | — | — | (F1) These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person. |